|Articles|February 15, 2008

Managed Care Issues in Glaucoma: Emerging Trends and Treatment
Volume 14
Issue 1 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 18 years ago

Article

The Prevalence of Glaucomatous Risk Factors in Patients From a Managed Care Setting: A Pilot Evaluation

over 18 years ago

Article

Disease Progression and the Need for Neuroprotection in Glaucoma Management

over 18 years ago

Article

Current Management of Glaucoma and the Need for Complete Therapy

over 18 years ago

Article

History of Neuroprotection and Rationale as a Therapy for Glaucoma

over 18 years ago

Article

Managed Care and the Impact of Glaucoma

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Participating Faculty

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk

Predicting GLP-1 Discontinuation From Pharmacy Claims

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Participating Faculty

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk

Predicting GLP-1 Discontinuation From Pharmacy Claims

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis